www.novartis.com
Open in
urlscan Pro
104.18.5.156
Public Scan
Submitted URL: http://novartis.com/
Effective URL: https://www.novartis.com/
Submission: On March 27 via manual from HK — Scanned from DE
Effective URL: https://www.novartis.com/
Submission: On March 27 via manual from HK — Scanned from DE
Form analysis
2 forms found in the DOMGET /search
<form action="/search" method="get" id="views-exposed-form-global-search-global-search" accept-charset="UTF-8">
<div class="wrap-global-search-result container">
<fieldset class="js-form-item js-form-type-search-api-autocomplete form-type-search-api-autocomplete js-form-item-keyword form-item-keyword form-no-label form-group">
<div>
<input placeholder="Search" data-drupal-selector="edit-keyword" data-search-api-autocomplete-search="global_search" class="form-autocomplete form-text form-control arc-input ui-autocomplete-input"
data-autocomplete-path="/search_api_autocomplete/global_search?display=global_search&&filter=keyword" type="text" id="edit-keyword" name="keyword" value="" size="30" maxlength="128" data-once="autocomplete search-api-autocomplete"
autocomplete="off">
</div>
</fieldset>
<fieldset class="js-form-item js-form-type-select form-type-select js-form-item-section form-item-section form-group">
<label for="edit-section">section</label>
<div>
<select data-drupal-selector="edit-section" multiple="multiple" name="section[]" id="edit-section" size="5" class="form-select form-control jqmsLoaded ms-list-1" style="display: none;">
<option value="6">Global</option>
<option value="3236">Digital</option>
<option value="3241">ESG</option>
<option value="26">Media Center</option>
<option value="2096">Careers</option>
</select>
<div id="ms-list-1" class="ms-options-wrap"><button type="button"><span>Global Search</span></button>
<div class="ms-options" style="min-height: 200px; max-height: 1180px;">
<ul style="column-count: 1; column-gap: 0px;">
<li data-search-term="global"><label for="ms-opt-1"><input type="checkbox" title="Global" id="ms-opt-1" value="6">Global</label></li>
<li data-search-term="digital"><label for="ms-opt-2"><input type="checkbox" title="Digital" id="ms-opt-2" value="3236">Digital</label></li>
<li data-search-term="esg"><label for="ms-opt-3"><input type="checkbox" title="ESG" id="ms-opt-3" value="3241">ESG</label></li>
<li data-search-term="media center"><label for="ms-opt-4"><input type="checkbox" title="Media Center" id="ms-opt-4" value="26">Media Center</label></li>
<li data-search-term="careers"><label for="ms-opt-5"><input type="checkbox" title="Careers" id="ms-opt-5" value="2096">Careers</label></li>
<li class="section-uncheck-all"><input type="button" onclick="sectionClearAll(); return false;" id="section-uncheck-all" class="uncheck-all" value="Clear All"></li>
</ul>
</div>
</div>
</div>
</fieldset>
<div data-drupal-selector="edit-actions" class="form-actions js-form-wrapper form-group" id="edit-actions">
<div>
<span class="d-block d-md-none globa_search_icon_mobile"></span><input data-drupal-selector="edit-submit-global-search" type="submit" id="edit-submit-global-search" value="Search"
class="button js-form-submit form-submit btn btn-primary form-control arc-input">
</div>
</div>
</div>
</form>
GET /search
<form action="/search" method="get" id="search-block-form" accept-charset="UTF-8" class="search-form search-block-form form-row">
<fieldset class="js-form-item js-form-type-textfield form-type-textfield js-form-item-keyword form-item-keyword form-no-label form-group">
<div>
<input placeholder="Search" id="edit-keys" data-drupal-selector="edit-keyword" type="text" name="keyword" value="" size="60" maxlength="128" class="form-text form-control arc-input">
</div>
</fieldset>
<div data-drupal-selector="edit-actions" class="form-actions js-form-wrapper form-group" id="edit-actions--2">
<div>
<input data-drupal-selector="edit-submit" type="submit" id="edit-submit" value="Search" class="button js-form-submit form-submit btn btn-primary form-control arc-input">
</div>
</div>
</form>
Text Content
Skip to main content * Search section GlobalDigitalESGMedia CenterCareers Global Search * Global * Digital * ESG * Media Center * Careers * LANGUAGE & COUNTRY SELECTOR FOR DESKTOP Global | en CHOOSE LOCATION * International * Americas * Asia Pacific * Europe * Middle East & Africa * Global | en * Sandoz | en * Novartis Foundation | en(link is external) * Argentina | es * Brazil | pt * Canada | en(link is external) * Canada | fr(link is external) * Central America | es * Colombia | es * Mexico | es * United States | en * Venezuela | es * Australia | en * Bangladesh | en * Hong Kong S.A.R. | zh * India | en(link is external) * Indonesia | en * Japan | ja(link is external) * Korea | ko(link is external) * Mainland China | zh * Malaysia | en * Pakistan | en * Philippines | en * Singapore | en * Taiwan | zh * Austria | de(link is external) * Belgium | fr(link is external) * Belgium | nl(link is external) * Bulgaria | bg(link is external) * Czech Republic | cs(link is external) * Czech Republic | en(link is external) * Denmark | da(link is external) * Estonia | et(link is external) * Finland | fi(link is external) * France | fr(link is external) * Germany | de(link is external) * Greece | el(link is external) * Hungary | hu(link is external) * Ireland | en(link is external) * Italy | it(link is external) * Latvia | lv(link is external) * Lithuania | lt(link is external) * Netherlands | nl(link is external) * Norway | no(link is external) * Poland | pl(link is external) * Portugal | pt(link is external) * Romania | ro * Russia | ru(link is external) * Serbia | sr(link is external) * Slovakia | sk(link is external) * Spain | es(link is external) * Sweden | sv(link is external) * Switzerland | de(link is external) * Switzerland | fr(link is external) * United Kingdom | en(link is external) * Egypt | en * Israel | he(link is external) * South Africa | en(link is external) * Turkey | tr LANGUAGE & COUNTRY SELECTOR FOR MOBILE Global CHOOSE LOCATION international International Americas Asia Pacific Europe Middle East & Africa * Argentina | es * Australia | en * Austria | de(link is external) * Bangladesh | en * Belgium | fr(link is external) * Belgium | nl(link is external) * Brazil | pt * Bulgaria | bg(link is external) * Canada | en(link is external) * Canada | fr(link is external) * Central America | es * Colombia | es * Czech Republic | cs(link is external) * Czech Republic | en(link is external) * Denmark | da(link is external) * Egypt | en * Estonia | et(link is external) * Finland | fi(link is external) * France | fr(link is external) * Germany | de(link is external) * Greece | el(link is external) * Hong Kong S.A.R. | zh * Hungary | hu(link is external) * India | en(link is external) * Indonesia | en * Ireland | en(link is external) * Israel | he(link is external) * Italy | it(link is external) * Japan | ja(link is external) * Korea | ko(link is external) * Latvia | lv(link is external) * Lithuania | lt(link is external) * Mainland China | zh * Malaysia | en * Mexico | es * Netherlands | nl(link is external) * Norway | no(link is external) * Global | en * Sandoz | en * Novartis Foundation | en(link is external) * Pakistan | en * Philippines | en * Poland | pl(link is external) * Portugal | pt(link is external) * Romania | ro * Russia | ru(link is external) * Serbia | sr(link is external) * Singapore | en * Slovakia | sk(link is external) * South Africa | en(link is external) * Spain | es(link is external) * Sweden | sv(link is external) * Switzerland | de(link is external) * Switzerland | fr(link is external) * Taiwan | zh * Turkey | tr * United Kingdom | en(link is external) * United States | en * Venezuela | es * Menu * About * Board of Directors * Joerg Reinhardt * Simon Moroney * Nancy C. Andrews * Ton Buechner * Patrice Bula * Elizabeth (Liz) Doherty * Ana de Pro Gonzalo * Bridgette Heller * Daniel Hochstrasser * Frans van Houten * Charles L. Sawyers * William T. Winters * John D. Young * Charlotte Pamer-Wieser * Executive Committee * Vasant (Vas) Narasimhan * Shreeram Aradhye * Victor Bulto * Aharon (Ronny) Gal * Karen L. Hale * Harry Kirsch * Rob Kowalski * Steffen Lang * Fiona Marshall * Klaus Moosmayer * Marie-France Tschudin * Lutz Hegemann * Kees Roks * Richard Saynor * Michael Willi * Strategy * People and Culture * Data and Digital * Products * Innovative Medicines * Sandoz * Diversity, Equity & Inclusion * Equity * Diversity, Equity & Inclusion Governance and Community * Inclusivity * Parental Leave * Society * Manufacturing * Quality * Audit program * Novartis Quality Management System (QMS) * Product and patient safety training * Regulatory inspections * Product recalls * Third-party suppliers * Awards and Recognition About Novartis * Patients and Caregivers * Novartis Commitment to Patients and Caregivers * Diseases * Patient Organization Funding * Stories: Patients Perspectives Patients & Caregivers * Healthcare Professionals * Medical Congresses and Events * Abstract summaries for EULAR * Abstract summaries for ACR * Products * Novartis Pipeline * Managed Access Programs * Novartis Gene Therapies Managed Access Program * Novartis External Funding * Healthcare Professional Resources by Country * Investigator-Initiated Trials / Studies * Transparency and Disclosure * Novartis Medical Information * Submit medical enquiry Healthcare Professionals * Research & Development * Novartis Institutes for BioMedical Research * Collaborations * NIBR Global Scholars Program * Technology Platforms * Radioligand Therapy * Gene Therapy * Cell Therapy * Research Disease Areas * Immuno-oncology research at Novartis * Oncology research at Novartis * Cardiovascular and metabolic disease research at Novartis * Autoimmunity, transplantation and inflammatory disease research at Novartis * Ophthalmology research at Novartis * Neuroscience Research at Novartis * Musculoskeletal Disease Research at Novartis * DAx: exploratory disease research at Novartis * Research Locations * Novartis Institute for Tropical Diseases * Novartis Pipeline * Translational Medicine * Research & Development Approach * Research Collaborations * Open Source Science * Stories from our Labs Research & Development * ESG * Access * Creating sustainable business models * Value-Based Pricing * Sub-Saharan Africa * Donations * Novartis Access Principles * Novartis Oncology Access * Patents and Licensing * Ethics, Risk and Compliance * Ethical Behavior * Compliance * Human Rights * Learning and Engagement * Risk management * Environmental Sustainability * Climate * Waste * Water * Global Health * Anti-Microbial Resistance (AMR) * Avoidable Blindness * Chagas Disease * Leprosy * Malaria * Sickle Cell Disease (SCD) * Novartis Foundation (link is external) * Diversity, Equity & Inclusion * Reporting * ESG Rating Performance * Codes, Policies and Guidelines * Materiality Assessment * Transparency and Disclosure * Targets * Positions * ESG Index Environmental, Social and Governance * Investors * Event Calendar * Financial Data * Novartis Annual Results * Novartis Quarterly Results * Novartis SEC Filings * Product Sales * Fixed-Income Securities * Expected Currency Impact * Share Data & Analysis * Share Monitor * Dividend Information * Share Ownership * Share Overview * Return On Investment Calculator * Shareholder Information * General Meetings * American Depository Receipts (ADR) * Share Buy-Back * Frequently Asked Questions * Company Overview * Corporate Governance * Novartis Annual Reporting Suite * Reporting Archive * Publications Order Form * ESG Investors * News * News Archive * Media Library * Stories * Subscribe News * Careers * Career Search * Our Teams * Careers in Commercial * Careers in Communications and Engagement * Careers in Consulting * Careers in Digital * Careers in Health, Safety & Environment * Careers in Information Technology (IT) * Careers in Medical & Development * Careers in People & Organization * Careers in Procurement * Careers in Research * Careers in Strategy * Careers in Manufacturing and Supply * Ethics, Risk & Compliance (ERC) * Careers in Legal * Career Programs * Community Exploration & Learning Lab (CELL) * Postdoc Program * Early Talent * US NIBR Internship Programs * International Careers * Personal Growth * Well-being Careers * Clinical Trials Clinical Trials * Partnering Partnering * Supplier Portal Supplier Portal * Report side effects * Contacts Contacts Home Header AT NOVARTIS, WE ARE REIMAGINING MEDICINE Previous Next ABOUT NOVARTIS We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible. ACCESS We are committed to bringing more of our medicines to more people, no matter where they are. PEOPLE AND CULTURE Novartis is building an Inspired, Curious and Unbossed culture. LATEST NEWS Mar 27, 2023 * Media Release NOVARTIS KISQALI® PHASE III NATALEE TRIAL MEETS PRIMARY ENDPOINT AT INTERIM ANALYSIS DEMONSTRATING CLINICALLY MEANINGFUL BENEFIT IN BROAD POPULATION OF PATIENTS WITH EARLY BREAST CANCER Mar 21, 2023 * Media Release SANDOZ RECEIVES US FDA APPROVAL FOR BIOSIMILAR HYRIMOZ® (ADALIMUMAB-ADAZ) HIGH-CONCENTRATION FORMULATION Mar 20, 2023 * Media Release NOVARTIS SHARES ZOLGENSMA LONG-TERM DATA DEMONSTRATING SUSTAINED DURABILITY UP TO 7.5 YEARS POST-DOSING; 100% ACHIEVEMENT OF ALL ASSESSED MILESTONES IN CHILDREN TREATED PRIOR TO SMA SYMPTOM ONSET All news NOVARTIS 2022 FINANCIAL RESULTS Novartis announced the company’s fourth quarter and 2022 full year financial results. SANDOZ SPIN-OFF Novartis has announced an intention to separate the Sandoz business to create a standalone company by way of a 100% spin-off. NOVARTIS IN SOCIETY INTEGRATED REPORT 2022 In 2022, we continued to reimagine medicine and deliver on our purpose to improve and extend people's lives. Learn more Previous Next COMPASSIONATE USE: PROVIDING ACCESS TO MUCH NEEDED TREATMENTS What happens when a patient’s only treatment hope rests with a promising but not yet locally approved therapy? At Novartis, we are providing a lifeline of access to innovative medicines under review or not yet approved locally when no other treatment options are available. Read more ENVIRONMENTAL, SOCIAL AND GOVERNANCE We have a responsibility and opportunity to lead the world in creating a positive social change, embracing societal impact as a core business objective. THE NOVARTIS COMMITMENT TO PATIENTS AND CAREGIVERS Novartis works with the patient community around the world to discover new ways to improve and extend people’s lives. NOVARTIS NAVIGATE NOVARTIS Navigate Novartis * Patients and Caregivers * Healthcare Professionals * Researchers * Job Seekers * Journalists * Investors * Partners * Suppliers TOPICS Topics * Clinical Trials * ESG * SpeakUp EXPLORE Explore * Stories * Diseases * Locations * Products * Novartis Pipeline NOVARTIS COMPANIES Novartis companies * Sandoz * Advanced Accelerator Applications * Gyroscope Therapeutics * * * * * FOOTER BOTTOM Footer Bottom © 2023 Novartis AG * Terms of Use * Privacy * Contacts * Cookie Settings * Site Map * Web Accessibility * Open Source Novartis Site Directory This site is intended for a global audience YOUR PRIVACY IS IMPORTANT FOR US. We use cookies to enhance your experience when visiting our websites: performance cookies show us how you use this website, functional cookies remember your preferences and targeting cookies help us to share content relevant to you. Select “Accept all” for giving your consent to all cookies, select “Cookie settings” for managing the different cookies or select “Reject all” for using only strictly necessary cookies. You can change your cookie settings at any point of time by pressing the cookie settings link on the website. Cookie Settings Reject all Accept all COOKIE PREFERENCE CENTER When you visit any website, it may store or retrieve information on your browser by using cookies. The cookies are set to expire when the information is no longer needed or after a maximum period of 13 months. You can choose to allow or not to allow some specific types of cookies. Click on the different category headings below to find out more. Please note that blocking some types of cookies may impact your experience on the site and the services we are able to offer. Accept all MANAGE CONSENT PREFERENCES STRICTLY NECESSARY COOKIES Always Active These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information. Cookies Details PERFORMANCE COOKIES Performance cookies These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance. Cookies Details FUNCTIONAL COOKIES Functional cookies These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly. Cookies Details TARGETING COOKIES Targeting cookies These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising. Cookies Details Back Button BACK Search Icon Filter Icon Clear checkbox label label Apply Cancel Consent Leg.Interest checkbox label label checkbox label label checkbox label label * View Cookies * Name cookie name Save choices